Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chui Yan Mah
Observed names:
Chui Y. Mah,
Mah, Chui Yan
Institutions:
South Australian Health and Medical Research Institute,
Freemasons Foundation Centre for Men's Health,
Adelaide University,
The University of Adelaide
Observed institutions:
South Australian Health and Medical Research Institute,
Freemasons Foundation Centre for Men's Health,
Adelaide University,
The University of Adelaide
ORCID:
0000-0002-8820-4037
Observed ORCID:
0000-0002-8820-4037
OpenAlex ID:
A5043562354
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
2020
·
Zeyad D Nassar
, Chui Yan Mah
, et al.
·
eLife
·
225
PDF
Peri‐prostatic adipose tissue: the metabolic microenvironment of prostate cancer
2018
·
Zeyad D. Nassar
, Adel T. Aref
, et al.
·
British Journal of Urology
·
110
PDF
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer
2021
·
Margaret M. Centenera
, Julia S. Scott
, et al.
·
Cancer Research
·
95
PDF
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition
2021
·
Lisa M. Butler
, Chui Yan Mah
, et al.
·
Cancer Research
·
90
PDF
Endocrine Disruptor Compounds—A Cause of Impaired Immune Tolerance Driving Inflammatory Disorders of Pregnancy?
2021
·
John E. Schjenken
, Ella S. Green
, et al.
·
Frontiers in Endocrinology
·
85
PDF
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2024
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
·
Cancer Research
·
61
PDF
Lipogenic effects of androgen signaling in normal and malignant prostate
2019
·
Chui Yan Mah
, Zeyad D. Nassar
, et al.
·
Asian journal of urology
·
61
PDF
LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness
2020
·
Patrick F. Asare
, Eugene Roscioli
, et al.
·
Frontiers in Oncology
·
52
PDF
Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer
2024
·
Chui Yan Mah
, An Dieu Trang Nguyen
, et al.
·
British Journal of Cancer
·
34
PDF
Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition
2020
·
Zeyad D. Nassar
, Chui Yan Mah
, et al.
·
Molecular Cancer Research
·
28
PDF
Integration of Multiple Spatial Omics Modalities Reveals Unique Insights into Molecular Heterogeneity of Prostate Cancer
2023
·
Wanqiu Zhang
, Xander Spotbeen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
20
PDF
The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin
2021
·
Pawanrat Tangseefa
, Sally K. Martin
, et al.
·
Bone Research
·
17
PDF
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
2023
·
Josephine A. Hinneh
, Joanna L. Gillis
, et al.
·
British Journal of Cancer
·
16
PDF
Abstract PO-036: ACSM1 and ACSM3 regulate fatty acid oxidation in prostate cancer to promote growth and protect against oxidative stress
2020
·
Raj Kumar Shrestha
, Scott Townley
, et al.
·
Cancer Research
·
2
Author response: Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
2020
·
Zeyad D Nassar
, Chui Yan Mah
, et al.
·
eLife
·
1
Lipid elongation in prostate cancer: an androgen regulated process and a novel therapeutic target
2019
·
Zeyad D Nassar
, Margaret M Centenera
, et al.
·
Oncology Abstracts
·
1
Metabolic rewiring that protects against ferroptosis underlies resistance to CDK4/6 inhibition in prostate cancer
2026
·
Hodgson, Joshua
, Devadason, Michelle
, et al.
·
Mendeley Data
Metabolic rewiring that protects against ferroptosis underlies resistance to CDK4/6 inhibition in prostate cancer
2026
·
Joshua T. Hodgson
, Michelle Devadason
, et al.
·
Cell Death and Disease
PDF
Figure S12 from ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2026
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
Dataset S1 from ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2026
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
Dataset S3 from ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2026
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
Figure S11 from ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2026
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
Figure S13 from ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2026
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
Figure S1 from ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2026
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
Table S1 from ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis
2026
·
Raj K. Shrestha
, Zeyad D. Nassar
, et al.
Show more works
View as search
Works count:
123
Citation count:
898
H-index:
13
I10-index:
13
Year
Topic
Type